New AntiVirals for Infections with Pandemic Potential

Project Information

NAVIPP

Grant agreement ID: 101137506

DOI

10.3030/101137506

EC signature date 22 November 2023

Start date 1 January 2024

End date 31 December 2028

Funded under

• Health

Total cost

€ 6 170 152,50

EU contribution

€ 6 170 152,50

Coordinated by

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (2)

NAVIPP’s DEC plan (initial plan)

Initial version of NAVIPP’s DEC plan

NAVIPP management handbook

Guidance for NAVIPP’s beneficiaries and affiliated entities about GA obligations, governance, reporting procedures, management framework, internal communication, etc.

Data Management Plan (1)

NAVIPP’s DMP (first version)

First version of NAVIPP’s DMP

Websites, patent fillings, videos etc. (1)

NAVIPP’s website

Publications

Peer reviewed articles (1)

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity

Author(s): Julia Revuelta; Luciana Rusu; Clara Frances-Gomez; Elena Trapero; Susana Iglesias; Eva Calvo Pinilla; Ana-Belén Blázquez; Alfonso Gutiérrez-Adán; Acsah Konuparamban; Oscar Moreno; María Gómez Martínez; Alicia Forcada-Nadal; María Luisa López-Redondo; Ana Isabel Avilés-Alía; Nadine Gougeard; Clara Marco-Marín; Anmol Adhav; Carolina Espinosa; Maria del Pilar Hernández-Sierra; Francisco Del Caño-Ochoa; Roberto Gozalbo-Rovira; Santiago Ramón-Maiques; Jeronimo Bravo; Vicente Rubio; Alberto Marina; José Luis Llácer; Jordi Llop; Miguel Ángel Martín Acebes; Ron Geller; Alfonso Fernández-Mayoralas
Published in: Communications Biology, 2025, ISSN 2399-3642
Publisher: Communications Biology
DOI: 10.1038/S42003-025-07763-Z